These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 37423000)

  • 1. Corrigendum to "Biological effective dose is associated with radiological toxicity after lung stereotactic ablative radiation therapy" [Radiother. Oncol. 183 (2023) 109552].
    Cases C; Benegas M; Sánchez M; Vollmer I; Casas F; Gomà C; Mollà M
    Radiother Oncol; 2023 Sep; 186():109776. PubMed ID: 37423000
    [No Abstract]   [Full Text] [Related]  

  • 2. Biological equivalent dose is associated with radiological toxicity after lung stereotactic ablative radiation therapy.
    Cases C; Benegas M; Sánchez M; Vollmer I; Casas F; Gomà C; Mollà M
    Radiother Oncol; 2023 Jun; 183():109552. PubMed ID: 36813167
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Corrigendum to "A feasibility study of high-dose hypofractionated carbon ion radiation therapy using four fractions for localized hepatocellular carcinoma measuring 3 cm or larger" [Radiother. Oncol. 132 (2019) 230-235].
    Shibuya K; Ohno T; Katoh H; Okamoto M; Shiba S; Koyama Y; Kakizaki S; Shirabe K; Nakano T
    Radiother Oncol; 2020 Feb; 143():126-127. PubMed ID: 32008869
    [No Abstract]   [Full Text] [Related]  

  • 4. Corrigendum to "Update of the systematic review of palliative radiation therapy fractionation for bone metastases" [Radiother. Oncol. 126 (2018) 547-557].
    Rich SE; Chow R; Raman S; Liang Zeng K; Lutz S; Lam H; Silva MF; Chow E
    Radiother Oncol; 2019 Jun; 135():201. PubMed ID: 30981439
    [No Abstract]   [Full Text] [Related]  

  • 5. Corrigendum to "Interaction between CIEDs and modern radiotherapy techniques: Flattening filter free-VMAT, dose-rate effects, scatter radiation, and neutron-generating energies" [Radiother Oncol 152 (2020) 196-202].
    Gauter-Fleckenstein B; Nguyen J; Jahnke L; Gaiser T; Rudic B; Büttner S; Wenz F; Borggrefe M; Tülümen E
    Radiother Oncol; 2021 Jan; 154():291. PubMed ID: 33460982
    [No Abstract]   [Full Text] [Related]  

  • 6. Corrigendum to "Single vs multiple fraction palliative radiation therapy for bone metastases: Cumulative meta-analysis" [Radiother Oncol 141 (2019) 56-61].
    Chow R; Hoskin P; Schild SE; Raman S; Im J; Zhang D; Chan S; Chiu N; Chiu L; Lam H; Chow E; Lock M
    Radiother Oncol; 2020 Jul; 148():115. PubMed ID: 32361023
    [No Abstract]   [Full Text] [Related]  

  • 7. Corrigendum to "Local control and postponement of systemic therapy after modest dose radiotherapy in oligometastatic myxoid liposarcomas" [Radiother. Oncol. 158 (2021) 33-39].
    Lansu J; van Houdt WJ; van Langevelde K; van den Ende PLA; van der Graaf WTA; Schrage Y; van Boven H; Scholten AN; Haas RL
    Radiother Oncol; 2021 Oct; 163():245. PubMed ID: 34243980
    [No Abstract]   [Full Text] [Related]  

  • 8. Corrigendum to "Why should radiation oncology do translational research?" [Rep Pract Oncol Radiother 2019;24(1):60-64].
    Cañas R; Linares I; Guedea F; Berenguer Francés MÁ
    Rep Pract Oncol Radiother; 2019; 24(2):151. PubMed ID: 30723386
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pulmonary function and quality of life after VMAT-based stereotactic ablative radiotherapy for early stage inoperable NSCLC: a prospective study.
    Ferrero C; Badellino S; Filippi AR; Focaraccio L; Giaj Levra M; Levis M; Moretto F; Torchio R; Ricardi U; Novello S
    Lung Cancer; 2015 Sep; 89(3):350-6. PubMed ID: 26164208
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Optimising Radiation Therapy Dose to the Swallowing Organs at Risk: An In Silico Study of feasibility for Patients with Oropharyngeal Tumours.
    Barnhart MK; Cartmill B; Ward EC; Brown E; Sim J; Saade G; Rayner S; Robinson RA; Simms VA; Smee RI
    Dysphagia; 2019 Dec; 34(6):869-878. PubMed ID: 30741335
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Corrigendum to "Dose painting by numbers based on retrospectively determined recurrence probabilities" [Radiother Oncol 122 (2017) 236-241].
    Grönlund E; Johansson S; Montelius A; Ahnesjö A
    Radiother Oncol; 2019 Feb; 131():243. PubMed ID: 30563693
    [No Abstract]   [Full Text] [Related]  

  • 12. Corrigendum to "Geometric uncertainties in voluntary deep inspiration breath hold radiotherapy for locally advanced lung cancer" [Radiother. Oncol. 118 (2016) 510-514].
    Josipovic M; Persson GF; Dueck J; Peter Bangsgaard J; Westman G; Specht L; Aznar MC
    Radiother Oncol; 2019 Apr; 133():230. PubMed ID: 30773227
    [No Abstract]   [Full Text] [Related]  

  • 13. Corrigendum to "Interaction between lymphopenia, radiotherapy technique, dosimetry, and survival outcomes in lung cancer patients receiving combined immunotherapy and radiotherapy" [Radiother Oncol 150 (2020) 114-120].
    Chen D; Patel RR; Verma V; Ramapriyan R; Barsoumian HB; Angelica Cortez M; Welsh JW
    Radiother Oncol; 2021 May; 158():332-334. PubMed ID: 33714536
    [No Abstract]   [Full Text] [Related]  

  • 14. Stereotactic ablative body radiosurgery (SABR) or Stereotactic body radiation therapy (SBRT).
    Folkert MR; Timmerman RD
    Adv Drug Deliv Rev; 2017 Jan; 109():3-14. PubMed ID: 27932046
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Brief Report on Radiological Changes following Stereotactic Ablative Radiotherapy (SABR) for Early-Stage Lung Tumors: A Pictorial Essay.
    Ronden MI; Palma D; Slotman BJ; Senan S;
    J Thorac Oncol; 2018 Jun; 13(6):855-862. PubMed ID: 29518554
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Response to "Stereotactic ablative radiotherapy in the framework of classical radiobiology: response to Drs. Brown, Diehn, and Loo." (Int J Radiat Oncol Biol Phys 2011;79:1599-1600) and "Influence of tumor hypoxia on stereotactic ablative radiotherapy (SABR): response to Drs. Mayer and Timmerman." (Int J Radiation Oncol Biol Phys 2011;78:1600).
    Song CW; Levitt SH; Park H
    Int J Radiat Oncol Biol Phys; 2011 Nov; 81(4):1193; author reply 1193-4. PubMed ID: 22036162
    [No Abstract]   [Full Text] [Related]  

  • 17. Corrigendum to "Including anatomical variations in robust optimization for head and neck proton therapy can reduce the need of adaptation" [Radiother Oncol 131 (2019) 127-134].
    Cubillos-Mesías M; Troost EGC; Lohaus F; Agolli L; Rehm M; Richter C; Stützer K
    Radiother Oncol; 2020 Mar; 144():231. PubMed ID: 32044167
    [No Abstract]   [Full Text] [Related]  

  • 18. Corrigendum to "Contiguous pattern spreading in patients with Hodgkin's disease" [Radiother. Oncol. 47 (1998) 7-16].
    Ludwig Roth S
    Radiother Oncol; 2020 Jun; 147():99. PubMed ID: 32259752
    [No Abstract]   [Full Text] [Related]  

  • 19. Corrigendum to: "Nuclear EGFR as a molecular target in cancer" [Radiother Oncol 108 (2013) 370-77].
    Brand TM; Iida M; Luthar N; Starr MM; Huppert EJ; Wheeler DL
    Radiother Oncol; 2019 Jan; 130():195. PubMed ID: 30442378
    [No Abstract]   [Full Text] [Related]  

  • 20. Erratum to: "Pancreatic cancer and SBRT: A new potential option?" [Rep. Pract. Oncol. Radiother. 20 (2015) 377-384].
    Hajj C; Goodman KA
    Rep Pract Oncol Radiother; 2015; 20(6):491. PubMed ID: 26696790
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.